Catalog No.:AA003BZ3

3959-23-7 | (Phenylsulfonyl)acetic acid

Name: Name:(Phenylsulfonyl)acetic acid
Brand: AABLOCKS
SKU: AA003BZ3
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

95%

in stock

$32.00 $23.00

- +

95%

in stock

$96.00 $67.00

- +

10g

95%

in stock

$143.00 $100.00

- +

25g

98%

in stock

$235.00 $164.00

- +

100g

98%

in stock

$682.00 $477.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA003BZ3

Chemical Name:

(Phenylsulfonyl)acetic acid

CAS Number:

3959-23-7

Molecular Formula:

C8H8O4S

Molecular Weight:

200.2117

MDL Number:

MFCD00025042

SMILES:

OC(=O)CS(=O)(=O)c1ccccc1

NSC Number:

32353

Properties

BP:

452.2°C at 760 mmHg

Storage:

Keep in dry area;Room Temperature;

Computed Properties

Complexity:

269

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

0.8

Downstream Synthesis Route

64-17-5

3959-23-7

7605-30-3

[1]JournalfurpraktischeChemie(Leipzig1954),1884,vol.<2>30,p.344Anm.

3959-23-7

72263-17-3

[1]JournalfurpraktischeChemie(Leipzig1954),1889,vol.<2>40,p.548

[2]Tetrahedron,1996,vol.52,p.2489-2514

[3]JournalofOrganicChemistry,1999,vol.64,p.8648-8659

[4]RussianChemicalBulletin,2007,vol.56,p.130-136

[5]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.4360-4363

[6]EuropeanJournalofOrganicChemistry,2014,vol.2014,p.6787-6795

[7]Patent:WO2016/168682,2016,A2.Locationinpatent:Paragraph0416

[8]OrganicLetters,2018,vol.20,p.4057-4061

3959-23-7

104-88-1

34101-22-9

[1]Patent:US2003/149109,2003,A1

[2]Patent:US2002/22666,2002,A1

[3]Patent:US6548553,2003,B2

[4]JournalofSulfurChemistry,2015,vol.36,p.413-421

[5]JournaloftheChemicalSociety,1954,p.1844,1846

3959-23-7

100-52-7

16212-06-9

[1]JournalofSulfurChemistry,2015,vol.36,p.413-421

[2]JournaloftheChemicalSociety,1954,p.1844,1846

3959-23-7

66074-00-8

[1]MedChemComm,2015,vol.6,p.1130-1136

[2]Patent:CN106946868,2017,A.Locationinpatent:Paragraph0487;0512;0514

[3]Patent:CN109761932,2019,A.Locationinpatent:Paragraph0162-0164

[4]Patent:WO2007/59311,2007,A2.Locationinpatent:Page/Pagecolumn63-64

[5]AntimicrobialAgentsandChemotherapy,2014,vol.58,p.4837-4847

[6]Patent:US2005/250783,2005,A1.Locationinpatent:Page/Pagecolumn36

[7]BioorganicandMedicinalChemistry,2014,vol.22,p.756-761

[8]JournaloftheChemicalSociety,1964,p.904-906

[9]BioorganicandMedicinalChemistryLetters,2007,vol.17,p.1062-1066

[10]BioorganicandMedicinalChemistry,2010,vol.18,p.3448-3456

[11]ChineseChemicalLetters,2010,vol.21,p.381-384

[12]Lettersindrugdesignanddiscovery,2010,vol.7,p.18-22

[13]JournalofMedicinalChemistry,2011,vol.54,p.3251-3259

[14]ChineseChemicalLetters,2011,vol.22,p.413-416

[15]Molecules,2012,vol.17,p.7556-7568

[16]InorganicChemistry,2012,vol.51,p.10317-10324

[17]AsianJournalofChemistry,2013,vol.25,p.3294-3296

[18]Patent:US2013/323271,2013,A1.Locationinpatent:Paragraph0418

[19]JournalofMedicinalChemistry,2014,vol.57,p.9343-9356

[20]ChemicalandPharmaceuticalBulletin,2014,vol.62,p.1185-1191

[21]JournalofMedicinalChemistry,2015,vol.58,p.4325-4338

[22]Steroids,2015,vol.101,p.7-14

[23]EuropeanJournalofMedicinalChemistry,2016,vol.123,p.523-531

[24]Molecules,2016,vol.21

[25]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.4191-4196

[26]Patent:CN103848795,2016,B.Locationinpatent:Paragraph0106;0107

[27]BioorganicandMedicinalChemistryLetters,2017,vol.27,p.98-101

[28]Patent:CN105622607,2016,A.Locationinpatent:Paragraph0026;0027;0028

[29]EuropeanJournalofMedicinalChemistry,2017,vol.136,p.131-143

[30]EuropeanJournalofMedicinalChemistry,2017,vol.135,p.414-423

[31]EuropeanJournalofMedicinalChemistry,2017,vol.137,p.88-95

[32]BioorganicandMedicinalChemistry,2017,vol.25,p.4407-4413

[33]Patent:CN103694238,2017,B.Locationinpatent:Paragraph0234

[34]Patent:CN106883277,2017,A.Locationinpatent:Paragraph0035;0036;0037

[35]Patent:CN106928210,2017,A.Locationinpatent:Paragraph0014;0042

[36]Patent:CN106928209,2017,A.Locationinpatent:Paragraph0038;0040

[37]MedicinalChemistryResearch,2018,vol.27,p.1198-1205

[38]Patent:CN109627169,2019,A.Locationinpatent:Paragraph0073;0078

[39]Patent:CN110128368,2019,A.Locationinpatent:Paragraph0057;0061;0062

[40]Bioorganicandmedicinalchemistryletters,2019

[41]EuropeanJournalofMedicinalChemistry,2020,vol.190

[42]EuropeanJournalofMedicinalChemistry,2020,vol.196

Literature

Title: 2,6-Dichloro-1-[(1E)-2-(phenyl-sulfon-yl)ethen-yl]benzene.

Journal: Acta crystallographica. Section E, Structure reports online 20110501

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS